Moreadith Randall, Chief Scientific Officer of Serina Therapeutics ($SER), made 39 open market sales of company shares over the last 365 days, totaling about $1 million. Her most recent sale occurred on February 2, 2026. These sales rank her 4,911th among 11,678 individual insiders by value sold, below the average of $8.6 million per insider and 6.37 transactions. She reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 267,686.0000 | 10,339,000 | 2.37% | 0.06% |
| March 23, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $2.86 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| March 23, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| March 19, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 39000 | $0.00 | 274,186.0000 | 10,339,000 | 12.45% | 0.38% |
| March 19, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 39000 | $2.50 | 0.0000 | 10,339,000 | 100.00% | 0.38% |
| March 19, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 39000 | $0.06 | 39,000.0000 | 10,339,000 | 9999.99% | 0.38% |
| Feb. 3, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | A | Stock Option (right to buy) | 69000 | $0.00 | 69,000.0000 | 10,339,000 | 9999.99% | 0.67% |
| Feb. 2, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 313,186.0000 | 10,339,000 | 2.03% | 0.06% |
| Feb. 2, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $3.03 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Feb. 2, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Jan. 28, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $3.57 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Jan. 28, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Jan. 28, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 319,686.0000 | 10,339,000 | 1.99% | 0.06% |
| Jan. 22, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2500 | $2.95 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Jan. 22, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2500 | $0.06 | 2,500.0000 | 10,339,000 | 9999.99% | 0.02% |
| Jan. 22, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2500 | $0.00 | 326,186.0000 | 10,339,000 | 0.76% | 0.02% |
| Jan. 20, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2000 | $0.06 | 2,000.0000 | 10,339,000 | 9999.99% | 0.02% |
| Jan. 21, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2000 | $3.00 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Jan. 21, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2000 | $0.06 | 2,000.0000 | 10,339,000 | 9999.99% | 0.02% |
| Jan. 20, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2000 | $3.07 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Jan. 21, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2000 | $0.00 | 328,686.0000 | 10,339,000 | 0.60% | 0.02% |
| Jan. 20, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2000 | $0.00 | 330,686.0000 | 10,339,000 | 0.60% | 0.02% |
| Jan. 13, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5416 | $0.06 | 5,416.0000 | 10,339,000 | 9999.99% | 0.05% |
| Jan. 14, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 1084 | $0.00 | 332,686.0000 | 10,339,000 | 0.32% | 0.01% |
| Jan. 14, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 1084 | $2.50 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Jan. 13, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5416 | $0.00 | 333,770.0000 | 10,339,000 | 1.60% | 0.05% |
| Jan. 14, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 1084 | $0.06 | 1,084.0000 | 10,339,000 | 9999.99% | 0.01% |
| Jan. 13, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5416 | $2.50 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Jan. 8, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 13000 | $2.69 | 0.0000 | 10,339,000 | 100.00% | 0.13% |
| Jan. 8, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 13000 | $0.00 | 339,186.0000 | 10,339,000 | 3.69% | 0.13% |
| Jan. 8, 2026 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 13000 | $0.06 | 13,000.0000 | 10,339,000 | 9999.99% | 0.13% |
| Dec. 23, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 4100 | $2.60 | 0.0000 | 10,339,000 | 100.00% | 0.04% |
| Dec. 23, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 4100 | $0.00 | 352,186.0000 | 10,339,000 | 1.15% | 0.04% |
| Dec. 23, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 4100 | $0.06 | 4,100.0000 | 10,339,000 | 9999.99% | 0.04% |
| Dec. 22, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5673 | $0.06 | 5,673.0000 | 10,339,000 | 9999.99% | 0.05% |
| Dec. 22, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5673 | $0.00 | 356,286.0000 | 10,339,000 | 1.57% | 0.05% |
| Dec. 22, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5673 | $2.67 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Dec. 16, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3227 | $0.06 | 3,227.0000 | 10,339,000 | 9999.99% | 0.03% |
| Dec. 16, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3227 | $0.00 | 361,959.0000 | 10,339,000 | 0.88% | 0.03% |
| Dec. 16, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3227 | $2.96 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Dec. 12, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 1700 | $0.06 | 1,700.0000 | 10,339,000 | 9999.99% | 0.02% |
| Dec. 12, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 1700 | $0.00 | 365,186.0000 | 10,339,000 | 0.46% | 0.02% |
| Dec. 12, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 1700 | $3.26 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Dec. 11, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3555 | $0.00 | 366,886.0000 | 10,339,000 | 0.96% | 0.03% |
| Dec. 11, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3555 | $3.24 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Dec. 11, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3555 | $0.06 | 3,555.0000 | 10,339,000 | 9999.99% | 0.03% |
| Dec. 10, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | A | Common Stock | 645 | $0.06 | 645.0000 | 10,339,000 | 9999.99% | 0.01% |
| Dec. 10, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 645 | $0.00 | 370,441.0000 | 10,339,000 | 0.17% | 0.01% |
| Dec. 9, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 600 | $0.00 | 371,086.0000 | 10,339,000 | 0.16% | 0.01% |
| Dec. 10, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 645 | $3.35 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Dec. 9, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 600 | $3.31 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Dec. 9, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 600 | $0.06 | 600.0000 | 10,339,000 | 9999.99% | 0.01% |
| Dec. 2, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 1500 | $3.91 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Dec. 2, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 1500 | $0.00 | 376,686.0000 | 10,339,000 | 0.40% | 0.01% |
| Dec. 3, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 371,686.0000 | 10,339,000 | 1.33% | 0.05% |
| Dec. 3, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5000 | $0.06 | 5,000.0000 | 10,339,000 | 9999.99% | 0.05% |
| Dec. 3, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5000 | $3.52 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Dec. 2, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 1500 | $0.06 | 1,500.0000 | 10,339,000 | 9999.99% | 0.01% |
| Nov. 25, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5965 | $3.90 | 5,965.0000 | 10,339,000 | 50.00% | 0.06% |
| Nov. 25, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5965 | $0.06 | 11,930.0000 | 10,339,000 | 100.00% | 0.06% |
| Nov. 25, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5965 | $0.00 | 378,186.0000 | 10,339,000 | 1.55% | 0.06% |
| Nov. 24, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 535 | $0.06 | 535.0000 | 10,339,000 | 9999.99% | 0.01% |
| Nov. 24, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 535 | $3.94 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Nov. 24, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 535 | $0.00 | 384,151.0000 | 10,339,000 | 0.14% | 0.01% |
| Nov. 18, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 384,686.0000 | 10,339,000 | 1.66% | 0.06% |
| Nov. 18, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Nov. 18, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $3.75 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Nov. 10, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 391,186.0000 | 10,339,000 | 1.63% | 0.06% |
| Nov. 10, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $4.10 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Nov. 10, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Nov. 5, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3398 | $0.06 | 3,398.0000 | 10,339,000 | 9999.99% | 0.03% |
| Nov. 5, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3398 | $0.00 | 397,686.0000 | 10,339,000 | 0.85% | 0.03% |
| Nov. 5, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3398 | $4.24 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Nov. 4, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3102 | $4.40 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Nov. 4, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3102 | $0.00 | 401,084.0000 | 10,339,000 | 0.77% | 0.03% |
| Nov. 4, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3102 | $0.06 | 3,102.0000 | 10,339,000 | 9999.99% | 0.03% |
| Oct. 28, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5551 | $4.96 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Oct. 28, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5551 | $0.00 | 404,186.0000 | 10,339,000 | 1.35% | 0.05% |
| Oct. 28, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5551 | $0.06 | 5,551.0000 | 10,339,000 | 9999.99% | 0.05% |
| Oct. 27, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 949 | $5.19 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Oct. 27, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 949 | $0.00 | 409,737.0000 | 10,339,000 | 0.23% | 0.01% |
| Oct. 27, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 949 | $0.06 | 949.0000 | 10,339,000 | 9999.99% | 0.01% |
| Oct. 20, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $4.97 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Oct. 20, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 410,686.0000 | 10,339,000 | 1.56% | 0.06% |
| Oct. 20, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Oct. 13, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 4326 | $5.20 | 0.0000 | 10,339,000 | 100.00% | 0.04% |
| Oct. 13, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 4326 | $0.00 | 417,186.0000 | 10,339,000 | 1.03% | 0.04% |
| Oct. 13, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 4326 | $0.06 | 4,326.0000 | 10,339,000 | 9999.99% | 0.04% |
| Aug. 26, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 45632 | $0.06 | 45,632.0000 | 7,359,000 | 9999.99% | 0.62% |
| Aug. 26, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 45632 | $0.00 | 421,512.0000 | 7,359,000 | 9.77% | 0.62% |
| Aug. 25, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2042 | $0.00 | 467,144.0000 | 7,359,000 | 0.44% | 0.03% |
| Aug. 26, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 45632 | $7.01 | 0.0000 | 7,359,000 | 100.00% | 0.62% |
| Aug. 25, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2042 | $5.65 | 0.0000 | 7,359,000 | 100.00% | 0.03% |
| Aug. 25, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2042 | $0.06 | 2,042.0000 | 7,359,000 | 9999.99% | 0.03% |
| Aug. 20, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2077 | $0.00 | 469,186.0000 | 7,359,000 | 0.44% | 0.03% |
| Aug. 18, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2227 | $5.25 | 0.0000 | 7,359,000 | 100.00% | 0.03% |
| Aug. 20, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2077 | $0.06 | 2,077.0000 | 7,359,000 | 9999.99% | 0.03% |
| Aug. 20, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2077 | $5.10 | 0.0000 | 7,359,000 | 100.00% | 0.03% |
| Aug. 18, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2227 | $0.00 | 471,263.0000 | 7,359,000 | 0.47% | 0.03% |
| Aug. 18, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2227 | $0.06 | 2,227.0000 | 7,359,000 | 9999.99% | 0.03% |
| Aug. 12, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5500 | $0.00 | 473,490.0000 | 7,359,000 | 1.15% | 0.07% |
| Aug. 12, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5500 | $5.25 | 0.0000 | 7,359,000 | 100.00% | 0.07% |
| Aug. 12, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5500 | $0.06 | 5,500.0000 | 7,359,000 | 9999.99% | 0.07% |
| Aug. 4, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5500 | $0.06 | 5,500.0000 | 7,359,000 | 9999.99% | 0.07% |
| Aug. 4, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5500 | $0.00 | 478,990.0000 | 7,359,000 | 1.14% | 0.07% |
| Aug. 4, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5500 | $5.17 | 0.0000 | 7,359,000 | 100.00% | 0.07% |
| July 29, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 4196 | $0.06 | 4,196.0000 | 7,359,000 | 9999.99% | 0.06% |
| July 29, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 4196 | $0.00 | 484,490.0000 | 7,359,000 | 0.86% | 0.06% |
| July 29, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 4196 | $6.50 | 0.0000 | 7,359,000 | 100.00% | 0.06% |
| July 28, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 488,686.0000 | 7,359,000 | 1.31% | 0.09% |
| July 28, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.89 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 28, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| July 21, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.34 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 21, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 495,186.0000 | 7,359,000 | 1.30% | 0.09% |
| July 21, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| July 14, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.01 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 14, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 501,686.0000 | 7,359,000 | 1.28% | 0.09% |
| July 14, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| July 7, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.67 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 7, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 508,186.0000 | 7,359,000 | 1.26% | 0.09% |
| July 7, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| June 30, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 514,686.0000 | 7,359,000 | 1.25% | 0.09% |
| June 30, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| June 30, 2025 | Serina Therapeutics, Inc. | $SER | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.78 | 0.0000 | 7,359,000 | 100.00% | 0.09% |